Hillsdale Investment Management Inc. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.

Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$417,956
+6.2%
15,400
+20.3%
0.04%
+5.6%
Q2 2023$393,472
-5.0%
12,800
+11.3%
0.04%
+2.9%
Q1 2023$414,345
-8.8%
11,5000.0%0.04%
-7.9%
Q4 2022$454,480
-0.8%
11,500
+0.9%
0.04%
-7.3%
Q3 2022$458,00011,4000.04%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders